{"transactions":[{"id":3026729,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":146228,"kind":"person","name":"Elliott Mark S","position":1,"cik":"0001309100","reported_name":"Elliott Mark S","relationship":{"officer":true,"officer_title":"CFO & COO"}}],"security":"Stock Option","published_at":"2020-09-18T17:30:23.000Z","date":"2020-09-16","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":300000,"derivative":{"exercise_price":2.6,"exercise_date":"2020-09-16","expiration_date":"2023-09-16","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001654954-20-010247","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309100/000165495420010247/section16.xml","form_type":"4"}},{"id":3248700,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":146228,"kind":"person","name":"Elliott Mark S","position":1,"cik":"0001309100","reported_name":"Elliott Mark S","relationship":{"officer":true,"officer_title":"CFO & COO"}}],"security":"Common stock","published_at":"2020-02-25T16:30:50.000Z","date":"2020-01-27","kind":"purchase","acquired":true,"shares":5000,"price":1.06,"value":5300.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The number of shares acquired by Mr. Elliott as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Elliott after giving effect to this acquisition includes (i) 50,000 shares held by him directly, and (ii) 1,680 shares held by his spouse."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The number of shares acquired by Mr. Elliott as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Elliott after giving effect to this acquisition includes (i) 50,000 shares held by him directly, and (ii) 1,680 shares held by his spouse."}],"balance_after":51680,"source":{"system":"sec-edgar","filing":"0001654954-20-001917","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309100/000165495420001917/section16.xml","form_type":"4"}},{"id":3309245,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":146228,"kind":"person","name":"Elliott Mark S","position":1,"cik":"0001309100","reported_name":"Elliott Mark S","relationship":{"officer":true,"officer_title":"CFO & COO"}}],"security":"Common Stock","published_at":"2020-01-16T07:00:41.000Z","date":"2020-01-14","kind":"purchase","acquired":true,"shares":15000,"price":1,"value":15000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The number of shares acquired by Mr. Elliott as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Elliott after giving effect to this acquisition includes (i) 45,000 shares held by him directly, and (ii) 1,680 shares held by his spouse."}],"balance_after":46680,"source":{"system":"sec-edgar","filing":"0001654954-20-000506","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309100/000165495420000506/section16.xml","form_type":"4"}},{"id":3912149,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":146228,"kind":"person","name":"Elliott Mark S","position":1,"cik":"0001309100","reported_name":"Elliott Mark S","relationship":{"officer":true,"officer_title":"CFO & COO"}}],"security":"Options grant","published_at":"2018-05-31T12:49:43.000Z","date":"2018-05-29","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":4.78,"exercise_date":"2019-01-01","expiration_date":"2028-05-29","underlying":"common stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001654954-18-006090","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309100/000165495418006090/section16.xml","form_type":"4"}},{"id":3912148,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":146228,"kind":"person","name":"Elliott Mark S","position":1,"cik":"0001309100","reported_name":"Elliott Mark S","relationship":{"officer":true,"officer_title":"CFO & COO"}}],"security":"Options grant","published_at":"2018-05-31T12:49:43.000Z","date":"2018-05-29","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":4.78,"exercise_date":"2018-05-29","expiration_date":"2028-05-29","underlying":"common sotck","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001654954-18-006090","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309100/000165495418006090/section16.xml","form_type":"4"}}]}